A A Sasahara, R T Wall, C B Harburg. Show Affiliations »
Abstract
Mesh： See more » Drug Hypersensitivity/etiologyFibrinolytic Agents/adverse effectsFibrinolytic Agents/pharmacologyFibrinolytic Agents/therapeutic useHemorrhage/chemically inducedHumansPulmonary Embolism/drug therapyStreptokinase/adverse effectsStreptokinase/pharmacologyStreptokinase/therapeutic useThrombophlebitis/drug therapyUrokinase-Type Plasminogen Activator/adverse effectsUrokinase-Type Plasminogen Activator/pharmacologyUrokinase-Type Plasminogen Activator/therapeutic use
Substances： See more » Fibrinolytic AgentsStreptokinaseUrokinase-Type Plasminogen Activator
Year: 1981 PMID： 7222662 PMCID： PMC1272532
Source DB: PubMed Journal: West J Med ISSN： 0093-0415